ABSTRACT
The genotype-phenotype relationship in PWS patients is important for a better understanding of the clinical phenotype and clinical characteristics of different genotypes of PWS in children. We aimed to explore the influence of specific gene changes on the clinical symptoms of PWS and the value of early screening and early intervention of the condition. All data in this study were extracted from the database of the XiaoPang Weili Rare Disease Care Center. The collected information included basic demographics, maternal pregnancy information, endocrine abnormalities, growth and development abnormalities, and other clinical phenotypes. The relationships between genotypes and phenotypes in the major categories of PWS were analyzed. A total of 586 PWS cases with confirmed molecular diagnosis and genotyping were included in this study. Among them, 83.8% belonged to the deletion type, 10.9% the uniparental disomy (UPD) type, and 5.3% the imprinting defect (ID) type. Age-wide comparison among the three groups: The rate of hypopigmentation in the deletion group was higher than that in the UPD group (88.8% vs. 60.9%; p < 0.05); A total of 62 patients (14.2%) had epilepsy; and no statistical significance was found among the three groups (p = 0.110). Age-wide comparison between the deletion and non-deletion types: the rate of skin hypopigmentation and epilepsy in the deletion group was significantly higher than that in the non-deletion group (88.8% vs. 68.4%, p < 0.001; 15.9% vs. 7.6%, p = 0.040). The intergroup comparison for the >2-year age group: there were significant intergroup differences in the language development delay among the three groups (p < 0.001). The incidence of delayed language development was the highest in the deletion group, followed by the UPD group, and the lowest in the ID group. The rates of obesity and hyperphagia in the deletion group were also higher than those in the non-deletion group (71.1% vs. 58.9%, p = 0.041; 75.7% vs. 62.0%, p = 0.016). There are significant differences in the rates of skin hypopigmentation and language developmental delay among the deletion, UPD, and ID genotypes. The patients with deletion type had significantly higher rates of lighter skin color, obesity, hyperphagia, language developmental delay, and epilepsy. The results of this study will help clinicians better understand the impact of different PWS molecular etiologies on specific phenotypes.
Subject(s)
Epilepsy , Hypopigmentation , Prader-Willi Syndrome , Child , Pregnancy , Female , Humans , Prader-Willi Syndrome/epidemiology , Prader-Willi Syndrome/genetics , Prader-Willi Syndrome/diagnosis , Uniparental Disomy/genetics , Phenotype , Hyperphagia/complications , Genetic Association Studies , China/epidemiology , Epilepsy/complications , Chromosomes, Human, Pair 15ABSTRACT
Guidance on indications for, and types of, feeding tubes recommended in Prader-Willi syndrome (PWS) is needed. A Global PWS Registry survey was developed to investigate nasogastric (NG) and gastrostomy (G) tube use and associated complications. Of 346 participants, 242 (69.9%) had NG-tubes, 17 (4.9%) had G-tubes, and 87 (25.1%) had both NG- and G-tubes. Primary indication for placement was "feeding difficulties and/or poor weight gain" for both NG- (90.2%) and G-tubes (71.2%), while "aspiration/breathing difficulties" was the procedural indication for 6.4% of NG-tubes and 23.1% of G-tubes. NG-tubes were generally removed by age 6 months (NG Only: 82.9%; NG/G: 98.8%), while G-tubes were often removed by age 2 years (G Only: 85.7%; NG/G: 70.5%). The severe complication rate from G-tubes was 31.7% and from NG-tubes was 1.2%. Overall, caregivers indicated the presence of an NG- or G-tube had a positive effect on quality of life. Feeding difficulties in PWS are largely managed by NG-tube alone. The severe complication rate from G-tubes was about 25 times higher than from NG-tubes; yet, G-tube placement rates have generally increased. G-tube placement puts individuals with PWS at risk for anesthesia and surgery-related complications and should be considered judiciously by a multidisciplinary team.
Subject(s)
Enteral Nutrition , Intubation, Gastrointestinal , Prader-Willi Syndrome , Registries , Humans , Prader-Willi Syndrome/complications , Prader-Willi Syndrome/epidemiology , Female , Male , Child, Preschool , Child , Infant , Intubation, Gastrointestinal/adverse effects , Enteral Nutrition/adverse effects , Adolescent , Gastrostomy/adverse effects , Adult , Young AdultABSTRACT
OBJECTIVE: To estimate the prevalence of epilepsy and febrile seizures and their association with genotype, i.e., 15q11-q13 deletions, uniparental chromosome 15 disomy (UPD) and other mutations, in the population with Prader-Willi syndrome (PWS). METHODS: A systematic search of Medline, Scopus, Web of Science and the Cochrane Library was conducted. Studies estimating the prevalence of seizures, epilepsy and febrile seizures in the PWS population were included. Meta-analyses of the prevalence of epilepsy and febrile seizures and their association with genotype using the prevalence ratio (PR) were performed. RESULTS: Fifteen studies were included. The prevalence of epilepsy was 0.11 (0.07, 0.15), similar to the prevalence of febrile seizures, with a prevalence of 0.09 (0.05, 0.13). The comparison "deletion vs. UPD" had a PR of 2.03 (0.90, 4.57) and 3.76 (1.54, 9.18) for epilepsy and febrile seizures. CONCLUSIONS: The prevalence of seizure disorders in PWS is higher than in the general population. In addition, deletions in 15q11-q13 may be associated with a higher risk of seizure disorders. Therefore, active screening for seizure disorders in PWS should improve the lives of these people. In addition, genotype could be used to stratify risk, even for epilepsy, although more studies or larger sample sizes are needed.
Subject(s)
Epilepsy , Prader-Willi Syndrome , Humans , Prader-Willi Syndrome/genetics , Prader-Willi Syndrome/complications , Prader-Willi Syndrome/epidemiology , Epilepsy/genetics , Epilepsy/epidemiology , Prevalence , Genotype , Chromosomes, Human, Pair 15/geneticsABSTRACT
OBJECTIVES: Few data on alveolar hypoventilation in Prader-Willi syndrome (PWS) are available and the respiratory follow-up of these patients is not standardized. The objectives of this study were to evaluate the prevalence of alveolar hypoventilation in children with PWS and identify potential risk factors. STUDY DESIGN: This retrospective study included children with PWS recorded by polysomnography (PSG) with transcutaneous carbon dioxide pressure (PtcCO2) or end-tidal CO2 (ETCO2) measurements, between 2007 and 2021, in a tertiary hospital center. The primary outcome was the presence of alveolar hypoventilation defined as partial pressure of carbon dioxide (pCO2) ≥ 50 mmHg during ≥2% of total sleep time (TST) or more than five consecutive minutes. RESULTS: Among the 57 included children (38 boys, median age 4.8 years, range 0.1-15.6, 60% treated with growth hormone [GH], 37% obese), 19 (33%) had moderate-to-severe obstructive sleep apnea syndrome (defined as obstructive apnea-hypopnea index ≥5/h) and 20 (35%) had hypoventilation. The median (range) pCO2 max was 49 mmHg (38-69). Among the children with hypoventilation, 25% were asymptomatic. Median age and GH treatment were significantly higher in children with hypoventilation compared to those without. There was no significant difference in terms of sex, BMI, obstructive or central apnea-hypopnea index between both groups. CONCLUSION: The frequency of alveolar hypoventilation in children and adolescents with PWS is of concern and may increase with age and GH treatment. A regular screening by oximetry-capnography appears to be indicated whatever the sex, BMI, and rate of obstructive or central apneas.
Subject(s)
Prader-Willi Syndrome , Sleep Apnea, Obstructive , Male , Adolescent , Child , Humans , Infant , Child, Preschool , Hypoventilation/etiology , Hypoventilation/complications , Prader-Willi Syndrome/complications , Prader-Willi Syndrome/epidemiology , Retrospective Studies , Carbon Dioxide , Sleep Apnea, Obstructive/complications , Sleep Apnea, Obstructive/epidemiology , Sleep Apnea, Obstructive/diagnosisABSTRACT
Introducción: El síndrome de Prader-Willi es una enfermedad genética, causada por deleciones de novo en la región 15q11q13 en el cromosoma paterno. Se caracteriza por falta de saciedad que conduce a obesidad mórbida, trastornos del comportamiento, discapacidad intelectual, baja estatura e hipogonadismo. Objetivo: Describir los resultados obtenidos del análisis e intervención multidisciplinar realizados en paciente diagnosticado con el síndrome de Prader-Willi. Presentación del caso: Análisis de caso clínico en menor de 8 años, sexo masculino, diagnosticado con síndrome de Prader-Willi, a través de intervención multidisciplinaria realizado en tres momentos: evaluación, diagnóstico e intervención con enfoque cognitivo conductual. Conclusiones: Las estrategias adoptadas generaron cambios significativos en el contexto familiar y social, entre ellas, apropiación de las recomendaciones suministradas, adopción de factores protectores, identificación de roles y optimización en la adherencia farmacológica. La atención a estas consideraciones proporciona mejoras, que apuntan a la calidad de vida y clínica del paciente(AU)
Introduction: Prader-Willi syndrome is a genetic disease caused by de novo deletions in the 15q11q13 region in the paternal chromosome. It is characterized by lack of satiety leading to morbid obesity, behavioral disorders, intellectual disability, short height and hypogonadism. Objective: To describe the results obtained from the multidisciplinary analysis and intervention performed in a patient diagnosed with Prader-Willi syndrome. Presentation of the clinical case: Clinical case analysis in an 8 years old child, male sex, diagnosed with Prader-Willi syndrome through a multidisciplinary intervention performed in three moments: assessment, diagnosis and intervention with cognitive behavioral approach. Conclusions: The strategies adopted generated significant changes in the social and family context, family´s appropriation of the recommendations provided, adoption of protective factors, roles identification and improving of adherence to treatment. By taking into account this considerations, improvements lead to clinic and life quality of the patient(AU)
Subject(s)
Humans , Male , Child , Prader-Willi Syndrome/therapy , Early Intervention, Educational/methods , Prader-Willi Syndrome/epidemiology , Family Health/educationABSTRACT
Objetivo: o presente artigo objetiva relatar um caso de síndrome de Prader-Willi (SPW). Discussão do caso: paciente de 15 anos, sexo masculino, que se apresentou com as principais características da síndrome: a obesidade móbida, baixa estatura, hipogononadismo e fáceis característica . K. B.R. teve seu diagnóstico suspeito com 4 dias de vida, quando apresentou reflexos diminuídos, hipotonia, choro fraco e dificuldade em mamar. Com aproximadamente 2 anos, iniciou exagerado ganho de oeso, justificado pela sua fome insaciável. Aos 5 anos de idade fez-se o diagnóstico clínico de SPW, que posteriormente foi confirmado pela avaliação genética. Comentários: a SPW é um distúrbio neurocomportamental que geralmente surge por uma deleção proximal do cromossomo 15 durante a gametogênese paterna. A incidência varia de 1 caso em 25.000 até 1 caso em 10.000 nascidos vivos. O quadro clínico é caracterizado por hipotonia neonatal, retardo mental moderado, hiperfagia e obesidade precoce, hipogonadismo, acromicria e fáceis característca. O diagnóstico é feito clinicamente, podendo ser confirmado pela análise do segmento cromossômico 15q11-q13, por meio da metilação ou da hibridização in situ. Não há tratamento específico eficaz. Atualmente, a administração de hormônio do crescimento é a opção mais aceita.
Subject(s)
Humans , Male , Adolescent , Prader-Willi Syndrome/diagnosis , Prader-Willi Syndrome/epidemiology , Intellectual Disability , Hypogonadism , Obesity, MorbidABSTRACT
El Sindrome de Prader-labhart-Willi (SPLW), se caracteriza por hipotonía infantil, hipogonadismo, retraso en el desarrollo psicomotor, seguido de hiperfagia, instauración de obesidad, corta estatura, anormal función intelectual como del comportamiento y un leve dismorfismo accesorio. La etiología permanece aún sin determinar, sin embargo se han encontrado alteraciones en el cromosoma 15 en un porcentaje variable de pacientes con SPLW. para detectar pacientes afectados con este sindrome, se evaluaron 5,080 individuos con retardo mental que acuden a los Centros de Educación Especial (C.E.E.) de Lima y Callao. Se encontraron 5 casos con el cuadro completo cuyas características concuerdan muy bien con lo reportado en la literatura; además utilizando la técnica de bandeo cromosómico no se hallaron anomalías en sus cariotipos. La baja incidencia de SPLW encontrada, se atribuye a la excesiva rigurosidad en los criterios diagnósticos y a la inasistencia de estos pacientes a lo C.E.E. causada por sus peculiares problemas de comportamiento. Se realiza una revisión bibliográfica de la entidad y se concluye que debe ampliarse el espectro de severidad de este sindrome al hacer el diagnóstico